(Q43057903)
Statements
Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy (English)
Andrew Dennis Smith
Shetal N Shah
Brian I Rini
Michael L Lieber